Media Archive
How does hot weather impact our hearts and how can we help avoid a serious situation? Dr. Kelly Wingerter discusses steps that can be taken toward summer heart health.
Antonio Abbate, MD PhD, Research In Motion
Antonio Abbate, MD PhD, Division of Cardiovascular Medicine, studies how inflammation impacts heart disease and how to block interleukin-1 so patients feel better.
A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and strokes – something no existing treatment has been able to do.
Dr. Christopher Kramer, chief of the Division of Cardiovascular Medicine at UVA Health, moderated the session when the findings were presented last month and shared with UVA Today the key takeaways from the studies.
Women’s heart health specialist Dr. Patricia Rodriguez-Lozano
Renal denervation is a minimally invasive procedure that targets nerve tissues that control blood pressure in the body.
There have been trials on this procedure over the last decade, and FDA approval in 2024 could make it a more common option for treating high blood pressure.
“The types of patients who currently we would say are appropriate for consideration of renal denervation are ones who have a medication-resistant high blood pressure. Namely on two or three or sometimes more medications and despite that unable to maintain adequate blood pressure control,” UVA Health Cardiologist Doctor Kanwar Singh said.